COPD: Learn More. Breathe Better. A Conversation Can Be the First Step
Unfortunately, symptoms of COPD often go unreported until the disease is in its late stages. Part of the reason for this is that many common symptoms of COPD, such as chronic cough or shortness of breath, can be mistaken by patients as a normal sign of aging or being out of shape. While campaigns such as the National Heart, Lung, and Blood Institute's (NHLBI’s) COPD Learn More Breathe Better® are working to raise awareness of the signs and symptoms of COPD, an open line of communication in the exam room continues to be one of the most effective tools to catch and treat this serious lung disease early.
Family physicians and primary care providers play an important role in the diagnosis and management of COPD. Providers should look for COPD in patients who are over 40 and have:
• Persistent or progressive dyspnea (difficult or labored breathing)
• Chronic cough or sputum production
• Decline in level of activity
Pulmonary function testing is useful for determining the severity of COPD and distinguishing it from asthma. Providers should also be aware that, while COPD is more likely if there is a history of smoking, genetic factors (like alpha-1 antitrypsin deficiency) and environmental or occupational exposures may also play a role. In fact, 10 to 20 percent of COPD cases may be due to environmental or occupational exposures.
While there is no cure for COPD, early diagnosis and treatment can help alleviate symptoms and improve quality of life. An increasing number of effective therapies are available for patients who have COPD, and an open conversation between patient and provider often can be the first step in helping patients breathe better.
CARDIOVASCULAR EPIDEMIOLOGY DIGITAL FORUM
Guest Contributor Dr. David C. Goff Offers Perspective on the Future of Epidemiology
We are pleased to welcome guest contributor, David C. Goff, Jr., M.D., Ph.D., chair of the American Heart Association (AHA) Council on Epidemiology and Prevention, and dean of the Colorado School of Public Health, who will help us mark the forum’s 1-year anniversary by sharing his perspective on the future of epidemiology:
Strong epidemiology has been a critical component of advances in public health over at least the past half-century and will remain important in the future. The potential contributions of strong epidemiology include further elucidation of the social determinants of health, the molecular determinants of health, and the comparative effectiveness of various interventions, whether based on changes in policies, systems, environments, behaviors, or the use of pharmacologic, biologic, or device-based therapies.
WORKING GROUP EXECUTIVE SUMMARY
Pulseless Electrical Activity—Definition, Causes, Mechanisms, Management, and Research Priorities for the Next Decade
Pulseless electrical activity (PEA) is recognized as an increasingly significant public health burden, since a greater proportion of out-of-hospital sudden cardiac arrests and resulting deaths have been associated with PEA, compared with ventricular tachycardia and ventricular fibrillation. In general, sudden cardiac arrests are a leading cause of death in adults in the United States, resulting in an estimated 200,000 to 450,000 deaths each year, and accounting for 50 percent of all cardiovascular deaths.
The NHLBI convened a working group in Bethesda, MD, in July 2012 to discuss current knowledge and future directions for research in prediction, prevention, and management of PEA, as well as to explore probable causal pathways.
NEWS FROM AN NHLBI-FUNDED INSTITUTION
UAB Researchers Discover Possible Treatment for Incurable Lung Disease
An NHLBI-supported research team at the University of Alabama at Birmingham (UAB) has discovered a new pathway that contributes to idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments. More importantly, they have also found a new potential treatment to block this pathway that leads to fibrosis, or scarring of the lungs.
® COPD Learn More Breathe Better is a trademark of the U.S. Department of Health and Human Services (HHS).
Please note that the photo on this page of the Future sign is not for public use.
Thank you for subscribing. The NHLBI provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. We would greatly appreciate a quick note at NHLBIinfo@nhlbi.nih.gov to let us know how you use this information and what information you would like to see in future newsletters.
You are receiving this email notification because you gave permission to the NHLBI to send you emails. We will not sell or rent your name and information to any third parties outside of the NHLBI. If you experience any difficulty or have questions, please contact us at NHLBIinfo@nhlbi.nih.gov or call (301) 592-8573, TTY (240) 629-3255.
National Heart, Lung, and Blood Institute
Office of Communications
Building 31, Room 4A10
31 Center Drive, MSC 2480
Bethesda, MD 20892-2480
The "Delete Account" link will unsubscribe you from every topic and delete your email address from the system. To unsubscribe from select topics, click on "Manage Subscriptions or Account Preferences."
If you have questions or problems with the subscription service, please contact email@example.com. If you have questions or comments about other NHLBI programs or activities, please contact firstname.lastname@example.org.
Last Updated April 2013